These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 24687332)
1. Novel hydrazine derivatives as selective DPP-IV inhibitors: findings from virtual screening and validation through molecular dynamics simulations. Tanwar O; Deora GS; Tanwar L; Kumar G; Janardhan S; Alam M; Shaquiquzzaman ; Akhter M J Mol Model; 2014 Apr; 20(4):2118. PubMed ID: 24687332 [TBL] [Abstract][Full Text] [Related]
2. Finding a Potential Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for Type-2 Diabetes Treatment Based on Molecular Docking, Pharmacophore Generation, and Molecular Dynamics Simulation. Meduru H; Wang YT; Tsai JJ; Chen YC Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27304951 [TBL] [Abstract][Full Text] [Related]
3. Discovery of tight-binding competitive inhibitors of dipeptidyl peptidase IV. Pascual Alonso I; Valiente PA; Valdés-Tresanco ME; Arrebola Y; Almeida García F; Díaz L; García G; Guirola O; Pastor D; Bergado G; Sánchez B; Charli JL Int J Biol Macromol; 2022 Jan; 196():120-130. PubMed ID: 34920066 [TBL] [Abstract][Full Text] [Related]
4. Combined Ligand-Based and Structure-Based Virtual Screening Approach for Identification of New Dipeptidyl Peptidase 4 Inhibitors. Upadhyay J; Gajjar A; Suhagia BN Curr Drug Discov Technol; 2019; 16(4):426-436. PubMed ID: 30255759 [TBL] [Abstract][Full Text] [Related]
5. In silico approaches to predict the potential of milk protein-derived peptides as dipeptidyl peptidase IV (DPP-IV) inhibitors. Nongonierma AB; Mooney C; Shields DC; FitzGerald RJ Peptides; 2014 Jul; 57():43-51. PubMed ID: 24793774 [TBL] [Abstract][Full Text] [Related]
6. Identification of a Novel Scaffold for Inhibition of Dipeptidyl Peptidase-4. Mishra A; Cross M; Hofmann A; Coster MJ; Karim A; Sattar A J Comput Biol; 2019 Dec; 26(12):1470-1486. PubMed ID: 31390221 [TBL] [Abstract][Full Text] [Related]
7. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2 Musoev A; Numonov S; You Z; Gao H Molecules; 2019 Aug; 24(16):. PubMed ID: 31394858 [TBL] [Abstract][Full Text] [Related]
8. Activity and selectivity cliffs for DPP-IV inhibitors: Lessons we can learn from SAR studies and their application to virtual screening. Ojeda-Montes MJ; Gimeno A; Tomas-Hernández S; Cereto-Massagué A; Beltrán-Debón R; Valls C; Mulero M; Pujadas G; Garcia-Vallvé S Med Res Rev; 2018 Sep; 38(6):1874-1915. PubMed ID: 29660786 [TBL] [Abstract][Full Text] [Related]
9. Exploration of DPP-IV inhibitors with a novel scaffold by multistep in silico screening. Uchida T; Wakasugi M; Kitamura T; Yamamoto T; Asakura M; Fujiwara R; Itoh T; Fujii H; Hirono S J Mol Graph Model; 2018 Jan; 79():254-263. PubMed ID: 29274572 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, structure-activity relationship, and pharmacophore modeling studies of pyrazole-3-carbohydrazone derivatives as dipeptidyl peptidase IV inhibitors. Wu D; Jin F; Lu W; Zhu J; Li C; Wang W; Tang Y; Jiang H; Huang J; Liu G; Li J Chem Biol Drug Des; 2012 Jun; 79(6):897-906. PubMed ID: 22381062 [TBL] [Abstract][Full Text] [Related]
11. Identification of novel human dipeptidyl peptidase-IV inhibitors of natural origin (part I): virtual screening and activity assays. Guasch L; Ojeda MJ; González-Abuín N; Sala E; Cereto-Massagué A; Mulero M; Valls C; Pinent M; Ardévol A; Garcia-Vallvé S; Pujadas G PLoS One; 2012; 7(9):e44971. PubMed ID: 22984596 [TBL] [Abstract][Full Text] [Related]
12. Mining of potential dipeptidyl peptidase-IV inhibitors as anti-diabetic agents using integrated Sharma S; Srivastava S; Shrivastava A; Malik R; Almalki F; Saifullah K; Alam MM; Shaqiquzzaman M; Ali S; Akhter M J Biomol Struct Dyn; 2020 Nov; 38(18):5349-5361. PubMed ID: 31813365 [TBL] [Abstract][Full Text] [Related]
13. Discovery of triazole-based uracil derivatives bearing amide moieties as novel dipeptidyl peptidase-IV inhibitors. Deng X; Han L; Zhou J; Zhang H; Li Q Bioorg Chem; 2017 Dec; 75():357-367. PubMed ID: 29096096 [TBL] [Abstract][Full Text] [Related]
14. Identification of Potential Dipeptidyl Peptidase (DPP)-IV Inhibitors among Yang Y; Shi CY; Xie J; Dai JH; He SL; Tian Y Molecules; 2020 Jan; 25(1):. PubMed ID: 31906524 [No Abstract] [Full Text] [Related]
15. Discovery of Nine Dipeptidyl Peptidase-4 Inhibitors from Zhao Z; Ma R; Ma Y; Zhao L; Wang L; Fang Y; Zhang Y; Wu X; Wang X Molecules; 2024 May; 29(10):. PubMed ID: 38792165 [TBL] [Abstract][Full Text] [Related]
17. The Discovery and Characterization of a Potent DPP-IV Inhibitory Peptide from Oysters for the Treatment of Type 2 Diabetes Based on Computational and Experimental Studies. Chen Z; Su X; Cao W; Tan M; Zhu G; Gao J; Zhou L Mar Drugs; 2024 Aug; 22(8):. PubMed ID: 39195477 [TBL] [Abstract][Full Text] [Related]
18. DPP-IV Inhibitory Potentials of Flavonol Glycosides Isolated from the Seeds of Kim BR; Kim HY; Choi I; Kim JB; Jin CH; Han AR Molecules; 2018 Aug; 23(8):. PubMed ID: 30103438 [TBL] [Abstract][Full Text] [Related]
19. Structural Dynamics of DPP-4 and Its Influence on the Projection of Bioactive Ligands. Pantaleão SQ; Philot EA; de Resende-Lara PT; Lima AN; Perahia D; Miteva MA; Scott AL; Honorio KM Molecules; 2018 Feb; 23(2):. PubMed ID: 29473857 [TBL] [Abstract][Full Text] [Related]
20. 3D QSAR and docking study of gliptin derivatives as DPP-IV inhibitors. Agrawal R; Jain P; Dikshit SN; Bahare RS Comb Chem High Throughput Screen; 2013 May; 16(4):249-73. PubMed ID: 23305140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]